How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
Research question: Clomiphene citrate (CC) is one of the first-line treatments for ovulation induction in women with anovulatory polycystic ovary syndrome (PCOS). However, nearly 1 out of 2 women is resistant to 50 mg/day of CC. The objective of this study is to investigate the clinical, biological,...
Main Authors: | Lucie Huyghe, Camille Robin, Agathe Dumont, Christine Decanter, Maeva Kyheng, Didier Dewailly, Sophie Catteau-Jonard, Geoffroy Robin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/15/4943 |
Similar Items
-
Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
by: Beril Gurlek, et al.
Published: (2020-03-01) -
Randomized interventional clinical trial to estimate the efficacy of clomiphene citrate versus letrozole in induction of ovulation in infertility
by: Yogindra Kumar Manohar Kabadi, et al.
Published: (2022-07-01) -
Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial
by: Pattraporn Chera-aree, et al.
Published: (2023-11-01) -
Letrozole and Clomiphene citrate versus Letrozole alone in ovulation induction for patients with Polycystic Ovarian Syndrome
by: Mostafa Mohamed Khodary, et al.
Published: (2022-07-01) -
Comparison Between Two Methods of Ovulation Induction: Clomiphene Alone and Clomiphene +Tamoxifen in PCOS Patients
by: Ali Hassan Mohammed
Published: (2019-11-01)